Nathan J. Dowden, Chief Operating Officer at Entrada Therapeutics, Inc. (TRDA), sold 4,293 shares at $15.13 ($65K) on 2022-09-21, disclosed to the SEC on 2022-09-23.
Scheduled sale ($65k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.13 | 3,275 | $50K | 76.4% |
| 2 | $15.07 | 1,018 | $15K | 23.6% |
| Total | $15.12 avg | 4,293 | $65K | 100% |
| Filing → |
| TRDA | SELL | 2024-09-30 | $14K | — | Filing → |
| TRDA | SELL | 2024-09-10 | $35K | — | Filing → |
| TRDA | SELL | 2024-08-20 | $873K | — | Filing → |